semaj83/ctmatch_classification huggingface dataset:
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Normal Pressure Hydrocephalus Walking difficulties in both legs which has developed gradually, not explained by other conditions, either in combination with mental impairment and urinary incontinence Brain CT or MRI findings of enlarged ventricles compared to established standards (minimum Evans ratio of 0.30 as measured by reviewing films) Mental impairment must be mild to moderate, emerging with or after the walking difficulties Age > or = 18 years old MMSE (Mini-mental status exam): < or = 10 Urinary incontinence  No or only minimal walking difficulties combined with severe dementia Severe medical problems with limited life expectancy (less than six months) Contraindications to surgery Lack of informed consent
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  TBI (Traumatic Brain Injury) Post Concussion Syndrome Post Traumatic Stress Disorder Chronic Post Traumatic Stress Disorder Adults, 18-65 years old One or more mild-moderate TBI's characterized by loss of consciousness due to blast injury that is a minimum of one year old and occurred after 9/11/2001 Absence of acute cardiac arrest or hemorrhagic shock at time of TBI Absence of intracranial neurosurgery post-TBI Disability Rating Scale of 0-3 Negative Michigan Alcohol Screening Test (MAST) Negative Drug Abuse Screening Test (DAST) Negative urine toxicology screen for drugs of abuse Negative pregnancy test in females Otherwise good health  Pulmonary disease that precludes HBOT Unstable medical conditions that are contraindicated in HBOT Severe confinement anxiety Pregnancy Other pre-TBI neurological diagnoses Pre or post TBI history of substance abuse Pre or post TBI history of alcoholism Participation in another experimental trial with active intervention High probability of inability to complete the experimental protocol Previous HBOT
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 10.0-85.0,  Aging Absence of the basic pathology that interferes directly in the balance  Neurological changes Cognitive impairment Orthopedic injury Use of orthoses for lower limb Obesity Exercise frequently (more than twice a week) The bearer of any commitment to stay in their standing position
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Intracranial Hemorrhages Spontaneous ICH (intraparenchymal), subdural hematoma (SDH) diagnosed by CT scanning ≤ 12 hours after onset of symptoms. In case of unknown time of symptom onset: time between last seen in healthy condition and first CCT ≤ 12 hours Therapy receiving vitamin K antagonists (VKA) International Normalized Ratio (INR) ≥ 2 Signed informed consent form, or signed informed consent by a legal representative, judicial consent in cases where no legal representative is available in time, or consent of an independent physician familiar with the indication in cases where the first three possibilities can not be realized  Patients with ICH not related to vitamin-K antagonist therapy or Patients with secondary ICH related to infarction, hemophilia or other coagulopathy, tumor, hemorrhagic infarction, cerebrovenous thrombosis, aneurysm, arteriovenous malformations (AVM) or severe trauma Deep Coma (GCS ≤ 5) at the time of admission or before intubation if intubated outside the hospital Known previous disability (mRS > 2 before stroke occurred) Acute myocardial ischemia, acute septicemia, acute crush injury, any history of acute hemorrhagic disseminated intravascular coagulation, acute thrombotic stroke Known history of intermittent claudication Known recent thrombotic event < 30 days Acute or known congestive heart failure (NYHA III, IV) Pulmonary edema Known liver failure (child-pugh-score C)
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Post-Traumatic Stress Disorder OEF/OIF Veteran meets DSM-IV for PTSD control group does not meet for PTSD  prior history of significant head injury (LOC > 30 minutes) or other neurological disorder (e.g., stroke, seizure, multiple sclerosis), learning disability or confirmed diagnosis of ADHD contraindication to MR imaging, failed malingering tests during testing, or a history of severe mental illness (i.e., Schizophrenia, Bipolar Disorder) individuals will be excluded if in the 30 days prior to the initial interview if they do not have stable housing (i.e., staying in same residence) have medication changes or have had a psychiatric hospitalization participants who meet DSM-IV for substance dependence will be excluded from the study individuals will also receive urine toxicology and Breathalyzer testing as the first procedure on the evaluation day (pre and post treatment and at 3 month follow up); participants who test positive for alcohol or recent substance use (e.g., methamphetamine) or report significant levels of drug or alcohol use if they are unable to abstain from substance use at three consecutive visits veterans who are currently engaged in therapy treatment for PTSD
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Traumatic Brain Injury Post-Traumatic Stress Disorder At least 18 years of age and non-active duty Either Normal (no history of head injury) -OR- TBI (injury since Jan. 1, 2002)  Incapable of informed consent or absence of legally authorized representative Incarcerated (or subject to court supervision) Known allergy to protocol contrast/imaging agent (or pregnant and unable to receive agent) MRI incompatible (i.e. implant, metal, > 300 lbs, severe claustrophobia)
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Delirium years of age or greater In the Emergency Department for less than 12 hour at the time of enrollment  Severe mental retardation or dementia Baseline communication barriers such as aphasia, deafness, blindness, or who are unable to speak English Refusal of consent Previous enrollment Comatose Out of the hospital before the assessments are completed
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 65.0-85.0,  Elderly between the ages of 65-85 independent in activities of daily living able to walk without assistance for at least 10 minutes cognitively intact (Mini Mental State Exam ≥24) reported 2 or more falls within 6 months prior to the beginning of the study  any neurological, orthopedic or any other impairment likely to impact gait severe visual impairments major depression as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM)
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Traumatic Brain Injury Age 18 or older Evidence of external head injury or facial trauma, or mechanism of injury consistent with brain trauma, including loss of consciousness or altered mental status Residence within 90 minutes driving time of University of Maryland Medical Center, and willingness to attend follow-up appointments  History of white matter disease or neurodegenerative disorders including Multiple Sclerosis, Huntington's Disease, Alzheimer's Disease, or Pick's Disease History of Stroke History of treatment or diagnosis of psychiatric conditions: Major Depressive Disorder (MDD), Bipolar Disorder (BPD), Schizophrenia, or Dementia of any type History of Brain Tumor Status post trauma due to asphyxiation Preexisting contraindications for Magnetic Resonance Imaging (MRI) Active Duty Military Status Police custody or prisoner status Pregnant women
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 75.0-999.0,  Delirium Elderly patient (≥ 75 years) Patient with planned hip fracture surgery within 48 hours after the hip fracture Patient willing and able to complete the requirements of this study including the signature of the written informed consent  Patient suffering from multiple fractures, pelvic fractures proximal, pathological fractures, femur fractures (i.e., fractures of the middle or distal femur) Disabling neuropsychiatric disorders (severe dementia, Alzheimer's disease, schizophrenia, depression) Brain trauma within 12 months prior to selection, history of stroke with residuals Patient suffering from delirium (CAM diagnosis) at selection Patient who cannot complete the pre-operative mental tests (CAM and/or MMSE) of this clinical trial Patient with Mini-Mental State Examination (MMSE) score < 24 at selection Patient known to susceptible to malignant hyperthermia Patient with elevated intra-cranial pressure Patient with a risk of high oxygen demand Patient with recent or ongoing myocardial infarction / damage
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Posttraumatic Stress Disorder Involved in or witnessed a car accident at least 6 months ago PTSD or distress or impairment in important areas of functioning following the car accident  moderate or severe head injury current mental health treatment for the MVA-related problem severe chronic pre-injury mental health problems
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 75.0-999.0,  Postoperative Delirium Male or female subject aged over 75 years Admission for a scheduled surgery (i.e. all oncologic digestive surgery , ureterostomy, nephrectomy or cystectomy, total hip or knee replacement) Participation agreement  Patients with a progressive and/or poorly managed psychiatric pathology (patients with stabilized depression could be included in the study)
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Aging Decrease in Ambulation Age 65 years and older Must reside in Greve in Chianti or Bagno A Ripoli, Italy Subjects with modertative cognitive problems will be included as long as the consent can be read and signed by by a first-degree relative of the participant or, in absence of first-degree relative, another relative living with or close to the participant  Children
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Healthy Japanese healthy elderly male and female ≥65 years old Have a BMI of ≥18 and ≤27 kg/m2 and weigh ≥ 45 kg Be able to understand and comply with the requirements of the study as judged by the investigator(s)  History of any clinically significant medical or neurologic disease or disorder History of gastrointestinal surgery or unintentional rapid weight loss Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of the study drug
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 75.0-999.0,  Displaced Olecranon Fractures in Elderly Patients Age ≥75 years Minimal, moderate or severe fragmentation of the olecranon Within two weeks of olecranon fracture  Patients unable to give informed consent Associated fractures to the coronoid, radial head and/or distal humerus Associated ligamentous injury, dislocation or subluxation Open fractures
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 50.0-999.0,  Head Trauma Traumatic Brain Injury Chronic Subdural Hematoma Completion of informed consent by the patient or a legally appointed guardian Age ≥ 50 years Sustained mild head trauma with visit to the emergency department of the Hadassah-Hebrew University Medical Center within 24 hours after trauma Low-dose aspirin therapy (75-100 mg) at time of head trauma Admission non contrast head CT with no evidence of intracranial hemorrhage or skull fracture, as assessed by the neurosurgical resident on call and confirmed by an attending neuroradiologist  Documented or suspected myocardial infarction within the last 12 mo Documented or suspected transient ischemic event or cerebrovascular accident within the last 12 months Coronary intervention within the last 6 mo Vascular stenting or bypass within the last 6 mo End-stage renal failure requiring dialysis Treatment with aspirin dose other than 75-100 mg Concomitant treatment by anti-coagulant or other anti-aggregant (e.g. warfarin, low molecular weight heparin, or clopidogrel)
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Contrast Media Induced Nephropathy Subjects of 18 years old or older CKD stage 3 according to GFR-MDRD equation Two consecutive stable plasma Creatinine levels during the last 2months Elective computed tomography (CT) with a nonionic low-osmolality radiographic contrast agent  Acute/ chronic renal failure. Acute renal failure is defined as a change in serum creatinine concentration of at least 0.5 mg/dL, or 25% from creatinine measured before the study to that of the day of the procedure Intercurrent illness: e.g. fever… etc Recent exposure to radiographic contrast media in the last month before enrollment Allergy to contrast agents, PDE inhibitors or NAC Hypotension Pregnancy and lactation Multiple Myeloma Intravenous diuretics therapy Therapy with any of the nephroprotective drugs 2 weeks before enrollment such as N.A.C. PED5 inhibitor or Carnitine for any reason Severe Congestive Heart Failure, Acute Myocardial Infarction, moderate to severe liver failure (Child-Pugh class B or C)
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 70.0-999.0,  Delirium ≥ 70 years old Undergoing any lumbar spine surgery, posterior cervical spine surgery, or anterior cervical spine surgery > 2 levels  MMSE < 15 Delirium at baseline Inability to speak and understand English Severe hearing impairment, resulting in inability to converse Planned use of intraoperative ketamine Planned use of intraoperative remifentanil, except for airway management pre-incision Arterial catheter not planned to be inserted
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Traumatic Brain Injury Trauma all patients with traumatic brain injury  patients without traumatic brain injury
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Chronic Subdural Hematoma Newly diagnosed chronic subdural hematoma by CT scan or MRI, operated within the last 48 hours Age 18 years or older Written informed consent from the patient to participate in the study  Moribund state of health prohibiting surgery Foreseeable difficulties in follow-up due to geographic reasons (e.g. patients living abroad) Recurrent hematoma if the first surgery was performed before study start CSH due to spontaneous spinal CSF fistula or meningeosis carcinomatosa Pregnancy Patient with Metastatic Disease
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Elderly Delirium of Unknown (Axis III) Etiology Intensive Care (ICU) Myopathy Over 60 year old Delirium according to the CAM-ICU (Confusion Assessment Method for Intensive Care Unit) informed consent (legal representatives)  unable to swallow pills previous allergy to donepezil Atrioventricular block of 2nd and 3nd degree
Patient description: An 85-year-old man is brought to the ER because of gradual decrease in his level of consciousness. In the last 3 days he stopped walking and eating by himself. He has had no fever, cough, rash or diarrhea. His daughter recalls that he had been involved in a car accident 3 weeks prior to his admission and had a normal head CT at that time.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Breast Cancer Patients must have a histologically confirmed diagnosis of invasive breast carcinoma with positive estrogen (ER) and/or progesterone-receptor (PR) status, and negative human epidermal growth factor receptor (HER)2, for whom standard adjuvant endocrine therapy is planned ER and PR positivity must be assessed according to American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines as either ER or PR ≥ 1% positive nuclear staining HER2 test result negativity must be assessed as per ASCO/CAP 2013 guidelines using IHC, ISH or both HER2 is negative if a single test (or all tests) performed in a tumor specimen show IHC negative (0 or 1+) ISH negative using single probe or dual probe. If IHC is 2+, evaluation for gene amplification (ISH) must be performed and the ISH must be negative; ISH is not required if IHC is 0 or 1+ HER2 equivocal is not eligible Patients must not have metastatic breast cancer (stage IV disease); patients with multifocal, multicentric, and synchronous bilateral, and primary inflammatory breast cancers are allowed Multifocal disease is defined as more than one invasive cancer < 2 cm from the largest lesion within the same breast quadrant